Acute myocardial infarction complicated by cardiogenic shock: In-hospital and mid-term results of invasive treatment in the National Institute of Cardiology, Warsaw-Anin;Ostry zawał serca powikłany wstrza̧sem kardiogennym: Wyniki szpitalne i średnioterminowe leczenia zabiegowego w Instytucie Kardiologii w Warszawie-Aninie

Kardiologia Polska

Volumn 58, Issue 5, 2003, Pages 366-373

  Karcz, Maciej ^a   Bekta, Paweł ^a   Kȩpka, Cezary ^a   Witkowski, Adam ^a   Konopka, Anna ^a   Chmielak, Zbigniew ^a   Demkow, Marcin ^a   Dȩbski, Artur ^a   Ciszewski, Andrzej ^a   Ciszewski, Michał ^a   Cedro, Krzysztof ^a   Skwarek, Mirosław ^a   Przyłuski, Jakub ^a   Kruk, Mariusz ^a   Ka̧dziela, Jacek ^a   Deptuch, Tomasz ^a   Banaszewski, Marek ^a   Szajewski, Tomasz ^a   Stȩpińska, Janina ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Acute myocardial infarction; Cardiogenic shock; Primary angioplasty; Prognosis

Indexed keywords

ABCIXIMAB;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONSURGICAL INVASIVE THERAPY; PATIENT TRANSPORT; ST SEGMENT ELEVATION; STENT; SYMPTOMATOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0038683374     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hands M.E., Rutherford J.D., Muller J.E. et al.: The in-hospital development of cardiogenic shock after acute myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. J. Am. Coll. Cardiol. 1989, 14, 40-6.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986, 1, 397-402.
3. Sanborn T.A., Sleeper L.A., Bates E.R. et al.: Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? J. Am. Coll. Cardiol. 2000, 36 (3 Suppl A), 1123-9.
4. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I findings. N. Engl. J. Med. 1985, 312, 932-6.
5. Hochman J.S., Sleeper L.A., Webb J.G. et al.: SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock, Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N. Engl. J. Med. 1999, 341, 625-34.
6. Hochman J.S., Sleeper L.A., White H.D. et al.: SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. One-year survival following early revascularization for cardiogenic shock. JAMA 2001, 285, 190-2.
7. Urban P., Stauffer J.C., Bleed D. et al.: A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multi-center Trial of Angioplasty for Shock - (S)MASH. Eur. Heart J. 1999, 20, 987-8.
8. Barbash I.M., Behar S., Battler A. et al.: Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterization facilities. Heart 2001, 86, 145-9.
9. Webb J.G., Sanborn T.A., Sleeper L.A. et al. for the SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am. Heart J. 2001, 141, 964-70.
10. Ga̧sior M., Zȩbik T., Wasilewski J. et al.: Porównanie wyników leczenia chorych z niepowikłanym zawałem serca oraz zawałem z obecnościa̧ wstrza̧su kardiogennego, leczonych angioplastyka̧ wieńcowa̧. Analiza z Rejestru ZABRZE. Folia Cardiol. 2002, 9, 425-33.
11. Poloński, L., Ga̧sior M., Lekston A. et al.: Leczenie zawału serca w ośrodku z 24-godzinnym dyzurem inwazyjnym. Kardiol. Pol. 2001, 55, 91-5.